Latest filing published 16 Nov 2018 for G1 Therapeutics, Inc., €86k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +22.7%Entry US$19.40 · Close at T+365 US$23.80
- +69.0%Entry US$20.00 · Close at T+365 US$33.80
- +41.4%Entry US$26.60 · Close at T+365 US$37.60
- -87.3%Entry US$152.20 · Close at T+365 US$19.40
- -72.3%Entry US$94.00 · Close at T+365 US$26.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Barclay A. Phillips: trading record in brief
Barclay A. Phillips discloses dealings in 4 companies, chiefly Acorda Therapeutics Inc, Novavax Inc and Cancervax Corp. Over a trading history stretching from 15 February 2006 to 15 November 2018, the count stands at 56 filings.
On the open market, the record shows 14 purchases worth €194k and 26 sales worth €5.3M. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 option exercises. So far in 2018, the count stands at no purchases and 1 sale.
Half of the purchases are above €15k and half below. On 3 out of 5 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 11 purchases old enough to measure, the stock rose over the following 90 days in 45% of cases; the median change was -1.3%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 16 November 2018: an option exercise of €86k, in G1 Therapeutics, Inc. The last insider purchase was made public on 1 August 2017, 3,386 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Barclay A. Phillips
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$19.4632.8% of flowCommon StockSEC:0001562180-18-004597:0
- 5,000 shares@ US$39.9267.2% of flowCommon StockSEC:0001562180-18-004597:1
- 2,057 shares@ US$0.896.0% of flowCommon StockSEC:0001209191-17-046949:0Canonical exit: 29 Oct 2017 (T+90)
- 25,000 shares@ US$0.83874.8% of flowCommon StockSEC:0001209191-17-031437:0Canonical exit: 9 Aug 2017 (T+90)
- 1,633 shares@ US$1.126.6% of flowCommon StockSEC:0001209191-17-007070:0Canonical exit: 1 May 2017 (T+90)
- 422 shares@ US$4.296.3% of flowCommon StockSEC:0001209191-16-135041:0Canonical exit: 29 Oct 2016 (T+90)
- 405 shares@ US$4.38100.0% of flowCommon StockSEC:0001209191-16-094484:0Canonical exit: 30 Apr 2016 (T+90)
- 18,656 shares@ US$13.20Common StockSEC:0001209191-15-067383:0
- 10,000 shares@ US$12.81Common StockSEC:0001209191-15-067383:1
- 764 shares@ US$2.28Common StockSEC:0001209191-15-063680:0Canonical exit: 29 Oct 2015 (T+90)
- 8,388 shares@ US$2.28Common StockSEC:0001209191-15-008917:0Canonical exit: 1 May 2015 (T+90)
- 5,000 shares@ US$4.11Common StockSEC:0001209191-14-062013:0Canonical exit: 1 Jan 2015 (T+90)
- 8,788 shares@ US$2.28Common StockSEC:0001209191-14-050156:0Canonical exit: 29 Oct 2014 (T+90)
- 5,000 shares@ US$4.25Common StockSEC:0001209191-14-022919:0Canonical exit: 23 Jun 2014 (T+90)
- 9,868 shares@ US$2.29Common StockSEC:0001209191-14-006705:0Canonical exit: 1 May 2014 (T+90)
- 0Common StockSEC:0001209191-13-035773:0Canonical exit: 10 Sept 2013 (T+90)
- 1,483 shares@ US$11.00Common StockSEC:0001181431-12-014705:0
- 250,580 shares0Common StockSEC:0001209191-09-052336:0
- 83,526 shares0Common StockSEC:0001209191-09-052336:1
- 17,500 shares@ US$2.33Common StockSEC:0001209191-09-052336:2
- 17,500 shares@ US$2.75Common StockSEC:0001209191-09-052336:3
- 35,000 shares@ US$6.10Common StockSEC:0001209191-09-052336:4
- 185,000 shares@ US$30.20Common StockSEC:0001179110-08-012227:0
- 1,202 shares@ US$30.22Common StockSEC:0001179110-08-012227:1
- 900 shares@ US$30.33Common StockSEC:0001179110-08-012227:2
25 of 54 declarations
